PL2292607T3 - Sposób syntezy związków organicznych - Google Patents

Sposób syntezy związków organicznych

Info

Publication number
PL2292607T3
PL2292607T3 PL10171942T PL10171942T PL2292607T3 PL 2292607 T3 PL2292607 T3 PL 2292607T3 PL 10171942 T PL10171942 T PL 10171942T PL 10171942 T PL10171942 T PL 10171942T PL 2292607 T3 PL2292607 T3 PL 2292607T3
Authority
PL
Poland
Prior art keywords
synthesis
organic compounds
compounds
organic
Prior art date
Application number
PL10171942T
Other languages
English (en)
Inventor
Stephan Abel
Murat Acemoglu
Bernhard Erb
Christoph Krell
Joseph Sclafani
Mark Meisenbach
Mahavir Prashad
Wen-Chung Shieh
Song Xue
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37149980&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2292607(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PL2292607T3 publication Critical patent/PL2292607T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/07—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms
    • C07C205/11—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings
    • C07C205/12—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings the six-membered aromatic ring or a condensed ring system containing that ring being substituted by halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/61—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms
PL10171942T 2005-06-09 2006-06-07 Sposób syntezy związków organicznych PL2292607T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68897605P 2005-06-09 2005-06-09
EP06772447A EP1896426B1 (en) 2005-06-09 2006-06-07 Process for the synthesis of organic compounds
EP10171942.5A EP2292607B1 (en) 2005-06-09 2006-06-07 Process for the synthesis of organic compounds

Publications (1)

Publication Number Publication Date
PL2292607T3 true PL2292607T3 (pl) 2014-09-30

Family

ID=37149980

Family Applications (3)

Application Number Title Priority Date Filing Date
PL10171941T PL2266961T3 (pl) 2005-06-09 2006-06-07 Proces syntezy związków organicznych
PL06772447T PL1896426T3 (pl) 2005-06-09 2006-06-07 Sposób syntezy związków organicznych
PL10171942T PL2292607T3 (pl) 2005-06-09 2006-06-07 Sposób syntezy związków organicznych

Family Applications Before (2)

Application Number Title Priority Date Filing Date
PL10171941T PL2266961T3 (pl) 2005-06-09 2006-06-07 Proces syntezy związków organicznych
PL06772447T PL1896426T3 (pl) 2005-06-09 2006-06-07 Sposób syntezy związków organicznych

Country Status (25)

Country Link
US (2) US7781597B2 (pl)
EP (3) EP1896426B1 (pl)
JP (2) JP5225078B2 (pl)
KR (2) KR101283109B1 (pl)
CN (6) CN102174020B (pl)
AR (1) AR057056A1 (pl)
AT (1) ATE540931T1 (pl)
AU (3) AU2006258050B2 (pl)
BR (1) BRPI0611683A2 (pl)
CA (4) CA2611280C (pl)
DK (2) DK2292607T3 (pl)
ES (3) ES2380489T3 (pl)
GT (1) GT200600202AA (pl)
HU (1) HUE028024T2 (pl)
IN (2) IN2014DN08588A (pl)
JO (1) JO2758B1 (pl)
MX (1) MX2007015609A (pl)
MY (1) MY146795A (pl)
PE (3) PE20100716A1 (pl)
PL (3) PL2266961T3 (pl)
PT (3) PT1896426E (pl)
RU (1) RU2446162C2 (pl)
SI (2) SI2292607T1 (pl)
TW (1) TWI380981B (pl)
WO (1) WO2006135640A2 (pl)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2526614T3 (es) 2004-03-05 2015-01-13 Nissan Chemical Industries, Ltd. Compuesto de benzamida sustituida con isoxazolina y agente de control de organismos nocivos
MY146795A (en) * 2005-06-09 2012-09-28 Novartis Ag Process for the synthesis of organic compounds
TW200803740A (en) 2005-12-16 2008-01-16 Du Pont 5-aryl isoxazolines for controlling invertebrate pests
TWI412322B (zh) 2005-12-30 2013-10-21 Du Pont 控制無脊椎害蟲之異唑啉
MX2009013469A (es) 2007-06-13 2010-01-20 Du Pont Insecticidas de isoxazolina.
TWI430995B (zh) 2007-06-26 2014-03-21 Du Pont 萘異唑啉無脊椎有害動物控制劑
MX368680B (es) 2007-06-27 2019-10-11 Du Pont Administración subcutánea de un derivado de isoxazol-benzamida para usarse en un método para proteger un mamífero de una pulga.
TWI461411B (zh) 2007-08-17 2014-11-21 Du Pont 製備５－鹵烷基－４，５－二氫異唑衍生物之方法
MX2010003557A (es) 2007-10-03 2010-04-12 Du Pont Compuestos de isoxazolina de naftaleno para el control de plagas de invertebrados.
TWI455919B (zh) * 2008-04-09 2014-10-11 Du Pont 製備３－三氟甲基查耳酮（ｃｈａｌｃｏｎｅ）之方法
WO2010009402A2 (en) * 2008-07-17 2010-01-21 Teva Pharmaceutical Industries Ltd. Nilotinib intermediates and preparation thereof
ES2394258T3 (es) 2008-11-05 2013-01-30 Teva Pharmaceutical Industries Ltd. Formas cristalinas de Nilotinib HCL
WO2010060074A1 (en) * 2008-11-24 2010-05-27 Teva Pharmaceutical Industries Ltd. Preparation of nilotinib and intermediates thereof
US20110053968A1 (en) 2009-06-09 2011-03-03 Auspex Pharmaceuticals, Inc. Aminopyrimidine inhibitors of tyrosine kinase
CA2799963C (en) 2010-05-27 2018-01-23 E. I. Du Pont De Nemours And Company Crystalline form of 4- [5 - [3 -chloro-5 - (trifluoromethyl) phenyl] -4,5 -dihydro-5 - (trifluoromethyl) -3 - isoxazolyl] -n- [2-0x0-2- [(2,2,2-trifluoroethyl)amino]ethyl] -1-naphthalenecarboxamide
RU2705577C2 (ru) 2011-12-30 2019-11-08 Ханми Фарм. Ко., Лтд. ПРОИЗВОДНЫЕ ТИЕНО[3,2-d]ПИРИМИДИНА, ОБЛАДАЮЩИЕ ИНГИБИРУЮЩЕЙ АКТИВНОСТЬЮ В ОТНОШЕНИИ ПРОТЕИНКИНАЗ
CN102592837B (zh) * 2012-03-12 2014-01-15 河北师范大学 制备超级电容器用四氯合金属季铵盐掺杂聚苯胺电极的方法
CN103694176B (zh) 2014-01-07 2015-02-18 苏州立新制药有限公司 尼洛替尼中间体的制备方法
CN104592122B (zh) * 2014-12-09 2018-01-23 凯莱英医药集团（天津）股份有限公司 3‑(4‑甲基‑1h‑咪唑‑1‑基)‑5‑(三氟甲基)苯胺的制备方法
CN105985293B (zh) * 2015-03-04 2018-04-03 埃斯特维华义制药有限公司 尼洛替尼中间体的制备方法
EP3095782A1 (en) 2015-05-18 2016-11-23 Esteve Química, S.A. New method for preparing 3-(4-methyl-1h-imidazol-1-yl)-5-(trifluoromethyl)benzenamine
CN107201532B (zh) * 2017-05-09 2019-08-27 吉林凯莱英医药化学有限公司 芳香化合物的硝化方法
US11053220B2 (en) 2018-01-01 2021-07-06 Laurus Labs Ltd Process for 3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl) aniline
CN108530364B (zh) 2018-04-10 2020-01-21 江苏创诺制药有限公司 一种3-(4-甲基-1h-咪唑-1-基)-5-三氟甲基苯胺单盐酸盐的晶型及其应用
TWI815137B (zh) 2018-06-15 2023-09-11 漢達生技醫藥股份有限公司 尼洛替尼十二烷基硫酸鹽之結晶
CA3136189A1 (en) * 2019-04-06 2020-10-15 Trinapco, Inc. Sulfonyldiazoles and n-(fluorosulfonyl)azoles, and methods of making the same
EP3904342A1 (en) 2020-04-28 2021-11-03 Grindeks, A Joint Stock Company Process for the preparation of 3-(trifluoromethyl)-5-(4-methyl-1h-imidazole-1-yl)-benzeneamine hydrochloride
CN114751836A (zh) * 2021-02-23 2022-07-15 成都硕德药业有限公司 3-(4-甲基-1h-咪唑-1-基)-5-(三氟甲基)苯胺合成方法及其中间体
CN114853734A (zh) * 2022-06-14 2022-08-05 海南鑫开源医药科技有限公司 一种尼洛替尼游离碱的制备方法
CN115626880B (zh) * 2022-11-15 2023-11-14 常州大学 3-硝基-5-氰基三氟甲苯的合成方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1051076A1 (ru) * 1982-04-09 1983-10-30 Алтайский политехнический институт Способ получени производных имидазола
GB8413685D0 (en) * 1984-05-29 1984-07-04 Pfizer Ltd Quinolone inotropic agents
NZ212209A (en) * 1984-05-29 1988-08-30 Pfizer Quinolone derivatives and pharmaceutical compositions
GB8502267D0 (en) * 1985-01-30 1985-02-27 Pfizer Ltd Quinolone inotropic agents
HN2001000008A (es) * 2000-01-21 2003-12-11 Inc Agouron Pharmaceuticals Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo
GB0023383D0 (en) * 2000-09-23 2000-11-08 Synprotec Ltd 3,5-Bis (Trifluormethyl)Benzene derivatives
AR037647A1 (es) 2002-05-29 2004-12-01 Novartis Ag Derivados de diarilurea utiles para el tratamiento de enfermedades dependientes de la cinasa de proteina
GB0215676D0 (en) * 2002-07-05 2002-08-14 Novartis Ag Organic compounds
GB0222514D0 (en) 2002-09-27 2002-11-06 Novartis Ag Organic compounds
CN1939910A (zh) * 2004-12-31 2007-04-04 孙飘扬 氨基嘧啶类化合物及其盐和其制备方法与药物用途
GT200600207A (es) * 2005-06-09 2007-01-15 Novartis Ag Proceso para la síntesis de compuestos orgánicos
MY146795A (en) * 2005-06-09 2012-09-28 Novartis Ag Process for the synthesis of organic compounds

Also Published As

Publication number Publication date
RU2007148238A (ru) 2009-07-20
CA2833394A1 (en) 2006-12-21
KR101283109B1 (ko) 2013-07-05
SI2292607T1 (sl) 2014-09-30
PT2266961E (pt) 2016-02-05
US20080200692A1 (en) 2008-08-21
PL1896426T3 (pl) 2012-06-29
ES2380489T3 (es) 2012-05-14
AR057056A1 (es) 2007-11-14
DK2266961T3 (en) 2016-01-25
ES2380489T8 (es) 2012-06-22
AU2010241374A1 (en) 2010-12-02
AU2011201044A1 (en) 2011-03-31
GT200600202AA (es) 2014-06-09
CA2611280A1 (en) 2006-12-21
WO2006135640A2 (en) 2006-12-21
IN2014DN08578A (pl) 2015-07-10
ES2558696T3 (es) 2016-02-08
PE20070109A1 (es) 2007-04-02
CN102174021B (zh) 2013-02-27
US20100280257A1 (en) 2010-11-04
CN102174020A (zh) 2011-09-07
CN102180836B (zh) 2012-11-21
PT2292607E (pt) 2014-06-24
EP2292607A3 (en) 2011-04-27
PT1896426E (pt) 2012-04-12
AU2010241374B2 (en) 2011-11-03
EP1896426B1 (en) 2012-01-11
JO2758B1 (en) 2014-03-15
PL2266961T3 (pl) 2016-04-29
CN101189212A (zh) 2008-05-28
CN102174020B (zh) 2012-11-07
CA2942046A1 (en) 2006-12-21
AU2006258050B2 (en) 2010-12-09
AU2006258050A1 (en) 2006-12-21
CN101189212B (zh) 2011-05-18
TWI380981B (zh) 2013-01-01
DK2292607T3 (da) 2014-06-30
CA2886482C (en) 2017-09-05
US8008504B2 (en) 2011-08-30
WO2006135640A3 (en) 2007-08-02
EP2292607B1 (en) 2014-04-09
JP2008546645A (ja) 2008-12-25
CN102180796A (zh) 2011-09-14
EP1896426A2 (en) 2008-03-12
CN102174019B (zh) 2013-02-13
CA2886482A1 (en) 2006-12-21
EP2266961B1 (en) 2015-10-21
EP2292607A2 (en) 2011-03-09
CA2833394C (en) 2016-03-29
CN102180836A (zh) 2011-09-14
MY146795A (en) 2012-09-28
ES2465522T3 (es) 2014-06-06
KR20080014010A (ko) 2008-02-13
RU2446162C2 (ru) 2012-03-27
JP5225078B2 (ja) 2013-07-03
KR20120099028A (ko) 2012-09-06
TW200716563A (en) 2007-05-01
JP2013035855A (ja) 2013-02-21
HUE028024T2 (en) 2016-11-28
KR101249199B1 (ko) 2013-04-03
PE20100716A1 (es) 2010-10-25
BRPI0611683A2 (pt) 2010-09-28
MX2007015609A (es) 2008-02-25
PE20100715A1 (es) 2010-10-25
CA2611280C (en) 2014-01-28
EP2266961A3 (en) 2011-07-27
IN2014DN08588A (pl) 2015-07-10
CN102174019A (zh) 2011-09-07
EP2266961A2 (en) 2010-12-29
CN102174021A (zh) 2011-09-07
SI2266961T1 (sl) 2016-02-29
US7781597B2 (en) 2010-08-24
ATE540931T1 (de) 2012-01-15

Similar Documents

Publication Publication Date Title
PL2266961T3 (pl) Proces syntezy związków organicznych
IL184426A0 (en) Combination of organic compounds
IL185110A0 (en) Processes for the production of organometallic compounds
IL185419A0 (en) Improved process for the synthesis of enantiomeric indanylamine derivatives
IL194508A0 (en) Process for synthesizing organoelemental compounds
EP1862442A4 (en) PROCESS FOR OXIDIZING ORGANIC COMPOUNDS
ZA200805545B (en) Fermentative production of organic compounds
PL1807395T3 (pl) Sposób syntezy n-alkoksyamin
GB0316546D0 (en) Process for the manufacture of organic compounds
ZA200805546B (en) Fermentative production of organic compounds
GB0614245D0 (en) Synthesis process
IL181355A0 (en) Process for producing n-halogenated organic compounds
GB0402262D0 (en) Process for the manufacture of organic compounds
ZA200709621B (en) Process for the synthesis of organic compounds
GB0521728D0 (en) Methods for the preparation of organic compounds
GB0521726D0 (en) Methods for the preparation of organic compounds
GB0521727D0 (en) Methods for the preparation of organic compounds
GB0505861D0 (en) Methods for the synthesis of heteroaromatic compounds
IL189574A0 (en) Process for preparing 1-substituted-5-acylimidazole compounds
GB0614246D0 (en) Synthesis process
PL376014A1 (pl) Sposób syntezy diorganosilanów drogą dysproporcjonowania hydrydosiloksanów
ZA200705493B (en) Combination of organic compounds
EP1846425A4 (en) METHOD FOR PRODUCING METAL ORGANIC COMPOUNDS
IL186460A0 (en) Process for preparing bicyclic compounds
ZA200802990B (en) Process for the synthesis of compounds for selectin inhibition